Operating Profit Endring Dato
AbbVie USD 3.2B 914M 2023-12
Aceragen USD -20608000 11.66M 2023-03
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Galectin Therapeutics USD -9166000 163K 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
Incyte USD 187.27M 27.44M 2023-12
Merck USD -1933000000 7.68B 2023-12



Galectin Therapeutics Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.